The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks
Open accessAbstract
Objective: To develop models for prediction of pre‐eclampsia (PE) based on maternal factors and biophysical and biochemical markers at 11–13 weeks' gestation. Methods: Screening study of singleton pregnancies at 11–13 weeks including 752 (2.2%) that subsequently developed PE and 32 850 that were unaffected by PE. Models were developed for the prediction of early PE, requiring delivery before 34 weeks, intermediate PE with delivery at 34–37 weeks and late PE delivering after 37 weeks. The data used for the models were firstly, maternal characteristics and history, uterine artery pulsatility index, mean arterial pressure and serum pregnancy‐associated plasma protein‐A obtained from the screening study and secondly, maternal serum or plasma concentration of placental growth factor, placental protein‐13, inhibin‐A, activin‐A, soluble endoglin, pentraxin‐3 and P‐selectin obtained from case‐control studies. Results: In screening for PE by maternal factors only at a fixed false positive rate of 5%, the estimated detection rates were 33.0% for early PE, 27.8% for intermediate PE and 24.5% for late PE. The respective detection rates in screening by a combination of maternal factors, biophysical and biochemical markers were 91.0, 79.4 and 60.9%. Conclusions: Effective prediction of PE can be achieved at 11–13 weeks' gestation. Copyright © 2011 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008
(2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02847.x · Cited by 2,994
Brown, M. A., Lindheimer, M. D., Swiet, M. D., Assche, A. V., & Moutquin, J.-M. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
Snijders, R., Noble, P., Sebire, N., Souka, A., & Nicolaides, K. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11280-6 · Cited by 1,572 · cited 1×
“…history and perform combined screening for aneuploidies by measurement of the fetal crown-rump length (CRL) and nuchal translucency (NT) thickness and maternal serum PAPP-A and free β-human chorionic gonadotrophin (β-hCG) (Robinson and Fleming, 1975; Snijders et al., 1998; Kagan et al., 2008a).”
A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS
Robinson, H. P., & Fleming, J. E. E. (1975) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1975.tb00710.x · Cited by 1,413
Bujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J.-C., & Giguère, Y. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181e9322a · Cited by 1,092
Irgens, H. U., Roberts, J. M., Reisæter, L., Irgens, L. M., & Lie, R. T. (2001) · BMJ · doi:10.1136/bmj.323.7323.1213 · Cited by 1,040
Subclassification of Preeclampsia
von Dadelszen, P., Magee, L. A., & Roberts, J. M. (2003) · Hypertension in Pregnancy · doi:10.1081/prg-120021060 · Cited by 763
Screening for fetal aneuploidies at 11 to 13 weeks
Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2637 · Cited by 642
Self-citationMake every mother and child count.
Spencer-Jones, J. (2005) · PubMed · Cited by 519
Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11–13 weeks
Syngelaki, A., Chelemen, T., Dagklis, T., Allan, L., & Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2642 · Cited by 498
Self-citationUterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre‐eclampsia
Plasencia, W., Maiz, N., Bonino, S., Kaihura, C., & Nicolaides, K. H. (2007) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5157 · Cited by 425
Self-citationKagan, K. O., Wright, D., Baker, A., Sahota, D., & Nicolaides, K. H. (2008) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5331 · Cited by 378
Self-citationEgbor, M., Ansari, T., Morris, N., Green, C., & Sibbons, P. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.00882.x · Cited by 358
Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach
Poon, L. C. Y., Kametas, N. A., Chelemen, T., Leal, A., & Nicolaides, K. H. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2009.45 · Cited by 330
Self-citationMoldenhauer, J. S., Stanek, J., Warshak, C., Khoury, J., & Sibai, B. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/s0002-9378(03)00576-3 · Cited by 323
Kagan, K. O., Wright, D., Spencer, K., Molina, F. S., & Nicolaides, K. H. (2008) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5332 · Cited by 293
Self-citationAkolekar, R., Zaragoza, E., Poon, L. C. Y., Pepes, S., & Nicolaides, K. H. (2008) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.6244 · Cited by 265
Self-citationPrediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks
Nanda, S., Savvidou, M., Syngelaki, A., Akolekar, R., & Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2636 · Cited by 254
Self-citationFirst‐trimester maternal serum pregnancy‐associated plasma protein‐A and pre‐eclampsia
Poon, L. C. Y., Maiz, N., Valencia, C., Plasencia, W., & Nicolaides, K. H. (2009) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.6280 · Cited by 237
Self-citationAbnormal Placentation, Angiogenic Factors, and the Pathogenesis of Preeclampsia
Silasi, M., Cohen, B., Karumanchi, S. A., & Rana, S. (2010) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2010.02.013 · Cited by 196
Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks
Karagiannis, G., Akolekar, R., Sarquis, R., Wright, D., & Nicolaides, K. H. (2011) · Fetal Diagnosis and Therapy · doi:10.1159/000321694 · Cited by 195
Self-citationYu, C. K. H., Khouri, O., Onwudiwe, N., Spiliopoulos, Y., & Nicolaides, K. H. (2008) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5252 · Cited by 183
Self-citationWitlin, A. G., Saade, G. R., Mattar, F., & Sibai, B. M. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.104224 · Cited by 177
Beta, J., Akolekar, R., Ventura, W., Syngelaki, A., & Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2662 · Cited by 159
Self-citationCombining Biochemical and Ultrasonographic Markers in Predicting Preeclampsia: A Systematic Review
Giguère, Y., Charland, M., Bujold, E., Bernard, N., Grenier, S., Rousseau, F., Lafond, J., Légaré, F., & Forest, J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.134080 · Cited by 150
Zhong, Y., Tuuli, M. G., & Odibo, A. O. (2010) · Prenatal Diagnosis · doi:10.1002/pd.2475 · Cited by 142
Poon, L. C. Y., Karagiannis, G., Staboulidou, I., Shafiei, A., & Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2520 · Cited by 115
Self-citationMaternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia
Akolekar, R., Syngelaki, A., Beta, J., Kocyłowski, R., & Nicolaides, K. H. (2009) · Prenatal Diagnosis · doi:10.1002/pd.2375 · Cited by 107
Self-citationPrediction of spontaneous preterm delivery from endocervical length at 11 to 13 weeks
Greco, E., Lange, A., Ushakov, F. B., Calvo, J. R., & Nicolaides, K. H. (2010) · Prenatal Diagnosis · doi:10.1002/pd.2640 · Cited by 103
Self-citationAkolekar, R., Bower, S. J., Flack, N. J., Bilardo, C. M., & Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2644 · Cited by 95
Self-citationFirst-Trimester Prediction of Macrosomia
Poon, L. C., Karagiannis, G., Stratieva, V., Syngelaki, A., & Nicolaides, K. H. (2010) · Fetal Diagnosis and Therapy · doi:10.1159/000318565 · Cited by 88
Self-citationMaternal plasma soluble endoglin at 11–13 weeks' gestation in pre‐eclampsia
Foidart, J., Munaut, C., Chantraine, F., Akolekar, R., & Nicolaides, K. H. (2010) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.7621 · Cited by 87
Self-citationPoon, L. C., Kametas, N. A., Valencia, C. M. M., Chelemen, T., & Nicolaides, K. H. (2010) · Hypertension in Pregnancy · doi:10.3109/10641955.2010.484086 · Cited by 87
Self-citationMaternal plasma inhibin A at 11–13 weeks of gestation in hypertensive disorders of pregnancy
Akolekar, R., Minekawa, R., Veduță, A., Infante, X. C. R., & Nicolaides, K. H. (2009) · Prenatal Diagnosis · doi:10.1002/pd.2279 · Cited by 65
Self-citationMaternal Serum Activin A at 11–13 Weeks of Gestation in Hypertensive Disorders of Pregnancy
Akolekar, R., Etchegaray, A., Zhou, Y., Maíz, N., & Nicolaides, K. H. (2009) · Fetal Diagnosis and Therapy · doi:10.1159/000235878 · Cited by 42
Self-citationMaternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy
Akolekar, R., Casagrandi, D., Livanos, P., Tetteh, A., & Nicolaides, K. H. (2009) · Prenatal Diagnosis · doi:10.1002/pd.2311 · Cited by 42
Self-citationMaternal Thyroid Function at 11–13 Weeks of Gestation
Ashoor, G., Kametas, N. A., Akolekar, R., Guisado, J., & Nicolaides, K. H. (2010) · Fetal Diagnosis and Therapy · doi:10.1159/000313301 · Cited by 39
Self-citationFirst-Trimester Prediction of Early Preeclampsia
Levine, R. J., & Lindheimer, M. D. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.129379 · Cited by 38
Maternal Plasma P-selectin at 11 to 13 Weeks of Gestation in Hypertensive Disorders of Pregnancy
Akolekar, R., Veduță, A., Minekawa, R., Chelemen, T., & Nicolaides, K. H. (2010) · Hypertension in Pregnancy · doi:10.3109/10641950903242683 · Cited by 12
Self-citation
Cited by
Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers
Akolekar, R., Syngelaki, A., Poon, L., Wright, D., & Nicolaides, K. H. (2013) · Fetal Diagnosis and Therapy · doi:10.1159/000341264 · Cited by 601
Self-citationScreening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation
Tan, M. Y., Syngelaki, A., Poon, L. C., Rolnik, D. L., O'Gorman, N., Delgado, J. L., Akolekar, R., Konstantinidou, L., Tsavdaridou, M., Galeva, S., et al. (2018) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.19112 · Cited by 438
Self-citationProtocol for Measurement of Mean Arterial Pressure at 11-13 Weeks' Gestation
Poon, L. C. Y., Zymeri, N. A., Zamprakou, A., Syngelaki, A., & Nicolaides, K. H. (2012) · Fetal Diagnosis and Therapy · doi:10.1159/000335366 · Cited by 260
Self-citationCombined screening for preeclampsia and small for gestational age at 11-13 weeks
Poon, L. C. Y., Syngelaki, A., Akolekar, R., Lai, J., & Nicolaides, K. H. (2013) · Fetal Diagnosis and Therapy · doi:10.1159/000341712 · Cited by 204
Self-citationPre-eclampsia part 2: prediction, prevention and management
Chaiworapongsa, T., Chaemsaithong, P., Korzeniewski, S. J., Yeo, L., & Romero, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.103 · Cited by 132
Metadata
- Authors
- Akolekar, R., Syngelaki, A., Sarquis, R., Zvanca, M., & Nicolaides, K. H.
- Venue
- Prenatal Diagnosis
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 31
- Issue
- 1
- Pages
- 66-74
- ISSN
- 0197-3851 (ISSN-L)
- 1097-0223
- OpenAlex
- W1996307378
- Cited by
- 444
- References
- 39
- FWCI
- 58.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
